Acquisition Announced

Lilly acquisition of Vaccine Company

US$1.6bn consideration

Announced 26 May 2026

Advisers

Target
Vaccine Company
Acquirer
Lilly
Target based in
United States
Buyer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.